Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Decitex 30 Injection

Prescription Icon
Prescription Required

Marketer

Sun Pharmaceutical Industries Ltd

Salt Composition

Decitabine (30mg)

Overview Decitex 30 Injection

Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) are treated with Decitex 30 Injection. Its use may extend to other conditions as directed by a physician. This medication is often administered intravenously as part of combination chemotherapy regimens, under strict medical supervision. Dosage and frequency are determined by your doctor based on your specific condition and may be adjusted. Precise adherence to the prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be apparent for several weeks or months; discontinuation should only occur with your doctor's approval. Common side effects include nausea, vomiting, diarrhea, headache, fever, and pneumonia. Decitex 30 Injection can lower blood cell counts, increasing infection risk. Regular blood tests monitoring blood cell levels, along with heart, liver, and uric acid levels, are essential. Prior to treatment, inform your doctor about any pre-existing heart, liver, or kidney conditions, and any medications, particularly anti-infectives, you are currently taking. Interactions with other drugs are possible, so complete medication disclosure is necessary. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is mandatory for both partners throughout the treatment period.

Uses of Decitex 30 Injection

Bone marrow failure disorder characterized by abnormal blood cell production | Hematologic malignancy

Major Benefits of Decitex 30 Injection:

This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.

Common Side effects of Decitex 30 Injection:

  • Nausea
  • Vomiting
  • Headache
  • Fever
  • Lung infection
  • Decreased white blood cell count (neutrophils)
  • Nosebleeds
  • Anemia (low number of red blood cells)
  • Low blood platelets
  • Diarrhea
  • Pneumonia

How to use Decitex 30 Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Decitex 30 Injection works:

Decitex 30 Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential nucleotide components, thereby inhibiting tumor growth and replication.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Decitex 30 Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Decitex 30 Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might consider its use only if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Administration of Decitex 30 Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.

DrivingDrivingUNSAFE

Administering Decitex 30 Injection may induce adverse reactions that impair driving ability. Fatigue or weakness following Decitex 30 Injection use can compromise safe driving.

KidneyKidneyCAUTION

For individuals with impaired kidney function, Decitex 30 Injection requires careful administration. Dosage modification of Decitex 30 Injection might be necessary. Physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Decitex 30 Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Decitex 30 Injection :

NA

Facts to Know About Decitex 30 Injection

LabelValue
Chemical Category Azacitidine Analog
Developing Habits No.
Treatment Category Cancer Treatments
Actions Metabolic Inhibitors

FAQs on Decitex 30 Injection

Decitex 30 Injection is non-vesicant and poses no known risk of significant local tissue damage if extravasation occurs.
Decitex 30 Injection efficacy varies depending on individual patient response, clinical condition, and the number of treatment cycles administered.
Decitex 30 Injection can cause hair loss (alopecia) as a side effect.
Decitex 30 Injection is a powder that a qualified oncologist administers via slow intravenous infusion (over 3 hours) in a hospital or clinic setting.
Decitex 30 Injection
4,553
MRP 5,546
17% off